Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. [electronic resource]
Producer: 20051121Description: 345-50 p. digitalISSN:- 1537-453X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Diarrhea -- chemically induced
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Fatigue -- chemically induced
- Female
- Gastrointestinal Diseases -- chemically induced
- Humans
- Irinotecan
- Male
- Middle Aged
- Nausea -- chemically induced
- Pancreatic Neoplasms -- drug therapy
- Radiotherapy, Adjuvant
- Survival Rate
- Thrombocytopenia -- chemically induced
- Vomiting -- chemically induced
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.